GlobeNewswire
Dublin, Feb. 26, 2021 (GLOBE NEWSWIRE) -- The "Global Single-Cell Multi-Omics Market (2020-2025): Focus on Product Type, Omics Type, Sample Type, Technique, Application, End User, Region, and Competitive Landscape - Analysis and Forecast, 2020-2025" report has been added to ResearchAndMarkets.com's offering. Key Companies ProfiledGlobal Single-Cell Multi-Omics Market to Reach $3,188.9 Million by 2025Healthcare experts have found the single-cell multi-omics market to be one of the most rapidly evolving markets, which is predicted to grow at a CAGR of 21.16% during the forecast period, 2020-2025. The market is driven by the need for the development of an advanced solution based on single-cell technology for clinical research in various applications such as cancer, rare disease, cell biology, and synthetic biology, among others.The market is favored by the development of single-cell technology-based solutions for visualization and analysis of cell heterogeneity, tumor microenvironment, and antibody development. The gradual increase in the prevalence of oncology and rare diseases globally has furthered the single-cell multi-omics market.Furthermore, several contract research organizations are focusing on the development of single-cell technology-based services, which enable simultaneous analysis of genomics, proteomics, and transcriptomics, providing deeper insights on a disease progression.Within the research report, the market is segmented on the basis of product type, sample type, omics type, technique, application, end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.Competitive LandscapeThe exponential rise in the application of precision medicine on the global level has created a buzz among companies to invest in the development of high-resolution multiplex diagnostics providing information on cellular interaction and tissue heterogeneity to understand disease biology and pathology. Due to technologically advanced solutions and intense market penetration, 10x Genomics, Inc. has been a pioneer and a significant competitor in this market.Other key players in the market are NanoString Technologies, Inc., RareCyte, Inc., Fluidigm Corporation, Becton, Dickinson and Company, Thermo Fisher Sciences, Fluxion Biosciences, Bio-Rad Laboratories, Inc., Namocell, Inc., 1Cell Bio, Inc., Mission Bio, Berkeley Lights, Takara Bio, Inc., Dolomite Bio, and Bio-Techne Corporation.On the basis of region, North America holds the largest share of the single-cell multi-omics market due to improved healthcare infrastructure, rise in per capita income, and availability of state-of-the-art research laboratories and institutions in the region. Apart from this, Asia-Pacific is anticipated to grow at the fastest CAGR of 21.53% during the forecast period 2020-2025.The market utilizes several technologies, such as barcoding, sequencing, mass cytometry, and microscopy, for the development of instruments and assays for single-cell analysis of tissue and cells to gain an understanding of cell heterogeneity and cellular mechanism. Each solution offered by the leading players is the combination of next-generation omics tools for application in several clinical areas, such as oncology, neurology, immunology, and pathology.Key Topics Covered: 1 Product Definition2 Scope of Work3 Research Methodology3.1 Primary Data Sources3.2 Secondary Data Sources3.3 Market Estimation Model3.4 Criteria for Company Profiling4 Market Overview4.1 Introduction4.1.1 Technological Development in Single-Cell Sequencing4.1.1.1 Advancements in Imaging Techniques for Single-Cell Sequencing4.1.1.2 Advancements in Single-Cell Collection and Analysis System5 Market Dynamics5.1 Overview5.2 Impact Analysis5.3 Market Drivers5.3.1 Increasing number of Large-Scale Genomics Studies Leveraging Single-Cell RNA Sequencing (sc-RNA)5.3.2 Increasing Adoption of Personalized Medicine for the Screening and Diagnostics of Genetic Disorders5.3.3 Increasing Disposable Income in Emerging Economies5.4 Market Restraints5.4.1 High Cost of Single-Cell Analysis and Integration of Data5.4.2 Limited Availability of Large Online Data Storage and Analysis Platforms5.5 Market Opportunities5.5.1 Massive Scope for Adoption of Genomic-Based Medicine in Emerging Nations5.5.2 Requirement for the Development of Advanced Solutions Based on Single-Cell Technology5.5.3 Increased Use of Single-Cell Technology Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan5.5.4 Expansion into New Research Applications such as Single-Cell Metabolomics6 Competitive Insights6.1 Market Share Analysis (by Company), 20196.2 Growth Share Analysis (Opportunity Mapping)6.2.1 By Company7 Global Single-Cell Multi-Omics Market (by Product Type)7.1 Instruments7.2 Consumables7.3 Software8 Global Single-Cell Multi-Omics Market (by Omics Type)8.1 Single-Cell Genomics8.2 Single-Cell Transcriptomics8.3 Single-Cell Proteomics9 Global Single-Cell Multi-Omics Market (by Sample Type)9.1 Human Samples9.1.1 Cancer Tissues9.1.2 Stem Cells9.1.3 Brain Cells9.1.4 Immune Cells9.1.5 Other Samples9.2 Animal Samples9.3 Microbial Samples10 Global Single-Cell Multi-Omics Market (by Technique)10.1 Single-Cell Isolation and Dispensing10.1.1 Fluorescence-Activated Cell Sorting (FACS)10.1.2 Manual Cell Picking10.1.3 Magnetic-Activated Cell Sorting (MACS)10.1.4 Laser Capture Microdissection10.1.5 Random Seeding10.1.6 Microfluidics10.1.7 Others10.2 Single-Cell Analysis10.2.1 Mass Cytometry10.2.2 Polymerase Chain Reaction10.2.3 Next-Generation Sequencing10.2.4 Mass Spectrometry10.2.5 Others11 Global Single-Cell Multi-Omics Market (by Application)11.1 Clinical Research11.1.1 Oncology11.1.2 Immunology11.1.3 Neurology11.1.4 Cell Therapy11.1.5 Cell Biology11.1.6 Others11.2 Translation Research11.3 Synthetic Biology12 Global Single-Cell Multi-Omics Market (by End User)12.1 Overview12.2 Research and Academic Laboratories12.3 Contract Research Organizations12.4 Biopharmaceutical and Biotech Companies12.5 Others End Users13 Global Single-Cell Multi-Omics Market (by Region)14 Company Profiles CellBio, Inc.Fluidigm Corporation10x Genomics, Inc.NanoString Technologies, Inc.Bio-Techne CorporationBio-Rad Laboratories, Inc.Mission BioDolomite BioFluxion BiosciencesBerkeley Lights, Inc.RareCyte, Inc.Becton, Dickinson and CompanyTakara Bio, Inc.Thermo Fisher Scientific Inc.Namocell, Inc. 15 Emerging Companies ProteonaBioTuring, Inc.Scipio Biosciences SASParse Biosciences, Inc.Shilps Sciences For more information about this report visit https://www.researchandmarkets.com/r/ws7d69 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900